Literature DB >> 31342058

Cryptococcus neoformans infection in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected patients at an inner-city tertiary care hospital in the Bronx.

Hyun Ah Yoon1, Uriel Felsen1, Tao Wang2, Liise-Anne Pirofski1.   

Abstract

Cryptococcus neoformans causes life-threatening meningoencephalitis. Human immunodeficiency virus (HIV) infection is the most significant predisposing condition, but persons with other immunodeficiency states as well as phenotypically normal persons develop cryptococcosis. We retrospectively reviewed medical records of all patients with a diagnosis of cryptococcosis between 2005 and 2017 at our inner-city medical center in the Bronx, an epicenter of AIDS in New York City, and analyzed demographic data, clinical manifestations, laboratory findings, treatment, and mortality for these patients. In sum, 63% of the cases over this 12-year period occurred in HIV-infected patients. And 61% of the HIV-infected patients were non-adherent with antiretroviral therapy, 10% were newly diagnosed with AIDS, and 4% had unmasking cryptococcus-associated immune reconstitution inflammatory syndrome. The majority were Hispanic or black in ethnicity/race. HIV-uninfected patients (47/126) were older (P < .0001), and the majority had an immunocompromising condition. They were less likely to have a headache (P = .0004) or fever (P = .03), had prolonged time to diagnosis (P = .04), higher cerebrospinal fluid (CSF) glucose levels (P = .001), less CSF culture positivity (P = .03), and a higher 30-day mortality (P = .03). Cases in HIV-uninfected patients were often unsuspected during their initial evaluation, leading to a delay in infectious diseases consultation, which was associated with mortality (P = .03). Our study indicates that HIV infection remains the most important predisposing factor for cryptococcosis despite availability of antiretroviral therapy and highlights potential missed opportunities for earlier diagnosis and differences in clinical and prognostic factors between HIV-infected and HIV-uninfected patients.
© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Entities:  

Keywords:  zzm321990 Cryptococcus neoformans infection; zzm321990 Cryptococcus-associated immune reconstitution inflammatory syndrome; HIV infection; infectious diseases consultation; mortality; solid organ transplant recipients

Mesh:

Substances:

Year:  2020        PMID: 31342058      PMCID: PMC7261607          DOI: 10.1093/mmy/myz082

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  58 in total

1.  Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.

Authors:  Mark W Tenforde; Margaret Mokomane; Tshepo Leeme; Raju K K Patel; Nametso Lekwape; Chandapiwa Ramodimoosi; Bonno Dube; Elizabeth A Williams; Kelebeletse O Mokobela; Ephraim Tawanana; Tlhagiso Pilatwe; William J Hurt; Hannah Mitchell; Doreen L Banda; Hunter Stone; Mooketsi Molefi; Kabelo Mokgacha; Heston Phillips; Paul C Mullan; Andrew P Steenhoff; Yohana Mashalla; Madisa Mine; Joseph N Jarvis
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

2.  Presentation and Mortality of Cryptococcal Infection Varies by Predisposing Illness: A Retrospective Cohort Study.

Authors:  Matthew A Hevey; Ige A George; Krunal Raval; William G Powderly; Andrej Spec
Journal:  Am J Med       Date:  2019-05-08       Impact factor: 4.965

3.  Cryptococcosis in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

Authors:  John W Baddley; Graeme N Forrest
Journal:  Clin Transplant       Date:  2019-04-14       Impact factor: 2.863

4.  Disseminated cryptococcosis in HIV-uninfected patients.

Authors:  Y-M Chuang; Y-C Ho; H-T Chang; C-J Yu; P-C Yang; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-04       Impact factor: 3.267

5.  Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

Authors:  David R Boulware; David B Meya; Conrad Muzoora; Melissa A Rolfes; Katherine Huppler Hullsiek; Abdu Musubire; Kabanda Taseera; Henry W Nabeta; Charlotte Schutz; Darlisha A Williams; Radha Rajasingham; Joshua Rhein; Friedrich Thienemann; Melanie W Lo; Kirsten Nielsen; Tracy L Bergemann; Andrew Kambugu; Yukari C Manabe; Edward N Janoff; Paul R Bohjanen; Graeme Meintjes
Journal:  N Engl J Med       Date:  2014-06-26       Impact factor: 91.245

6.  Cryptococcal infections in non-HIV-infected patients.

Authors:  Peter G Pappas
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

7.  Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression.

Authors:  Hsin-Yun Sun; Barbara D Alexander; Shirish Huprikar; Graeme N Forrest; Didier Bruno; G Marshall Lyon; Dannah Wray; Leonard B Johnson; Costi D Sifri; Raymund R Razonable; Michele I Morris; Valentina Stosor; Marilyn M Wagener; Nina Singh
Journal:  Clin Infect Dis       Date:  2014-09-09       Impact factor: 9.079

8.  Epidemiology and trends of cryptococcosis in the United States from 2000 to 2007: A population-based study.

Authors:  Abdel Am Shaheen; Ranjani Somayaji; Robert Myers; Christopher H Mody
Journal:  Int J STD AIDS       Date:  2017-10-03       Impact factor: 1.359

Review 9.  The war on cryptococcosis: A Review of the antifungal arsenal.

Authors:  Ahmad Mourad; John R Perfect
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02-19       Impact factor: 2.743

10.  Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status.

Authors:  Kyle D Brizendine; John W Baddley; Peter G Pappas
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more
  7 in total

Review 1.  Pathogen and host genetics underpinning cryptococcal disease.

Authors:  Carolina Coelho; Rhys A Farrer
Journal:  Adv Genet       Date:  2020-03-18       Impact factor: 3.880

2.  Cryptococcal infection in renal transplant: two case reports and a literature review.

Authors:  M D Rojo-Martin; I de Toro Peinado; J D Ruiz Mesa; B Palop Borrás
Journal:  Rev Esp Quimioter       Date:  2021-02-28       Impact factor: 1.553

3.  Missed opportunities to identify cryptococcosis in COVID-19 patients: a case report and literature review.

Authors:  Daniel B Chastain; Andrés F Henao-Martínez; Austin C Dykes; Gregory M Steele; Laura Leigh Stoudenmire; Geren M Thomas; Vanessa Kung; Carlos Franco-Paredes
Journal:  Ther Adv Infect Dis       Date:  2022-01-15

Review 4.  Pathogen-Host Interaction Repertoire at Proteome and Posttranslational Modification Levels During Fungal Infections.

Authors:  Yanjian Li; Hailong Li; Tianshu Sun; Chen Ding
Journal:  Front Cell Infect Microbiol       Date:  2021-12-02       Impact factor: 5.293

Review 5.  Cerebral Cryptococcomas: A Systematic Scoping Review of Available Evidence to Facilitate Diagnosis and Treatment.

Authors:  Daniel B Chastain; Amy Rao; Armaan Yaseyyedi; Andrés F Henao-Martínez; Thomas Borges; Carlos Franco-Paredes
Journal:  Pathogens       Date:  2022-02-03

6.  Cryptococcal Meningitis in an Immunocompetent Man Exposed to a Pet Cockatoo: An Overlooked Zoonosis.

Authors:  Diego P Peralta; Haya Najjar; Jessica Garcia-Chan
Journal:  Cureus       Date:  2022-08-17

7.  Shift in Epidemiology of Cryptococcal Infections in Ottawa with High Mortality in Non-HIV Immunocompromised Patients.

Authors:  Vishesh Patel; Marc Desjardins; Juthaporn Cowan
Journal:  J Fungi (Basel)       Date:  2019-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.